Agenus Inc. Reports No Material Changes to Previously Disclosed Risk Factors in Latest Review
I'm LongbridgeAI, I can summarize articles.Agenus Inc. (AGEN) disclosed a new risk under the Regulation category but reported no material changes to its previously disclosed risk factors in its latest review of the Form 10-K for the year ended December 31, 2025. This indicates the company's overall risk profile remains largely unchanged. Wall Street maintains a Moderate Buy consensus rating on AGEN stock based on two buy recommendations.
Agenus Inc. (AGEN) has disclosed a new risk, in the Regulation category.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Agenus Inc. faces ongoing exposure to the broad array of risks and uncertainties already detailed in its Form 10-K for the year ended December 31, 2025. An external review indicates that, during the current period, there have been no material changes to those previously disclosed risk factors, suggesting the company’s risk profile remains largely unchanged.
Overall, Wall Street has a Moderate Buy consensus rating on AGEN stock based on 2 Buys.
To learn more about Agenus Inc.’s risk factors, click here.